VALPROATE DE SODIUM TEVA SANTE L.P. 500 mg, film-coated tablet scored with extended release 30 tablets
Active ingredients: Sodium valproate
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored with extended release30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VALPROATE DE SODIUM TEVA SANTE L.P. 500 mg, comprimé pelliculé sécable à libération prolongée
- Pharmaceutical form
- comprimé pelliculé sécable à libération prolongée
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium de 30 comprimé(s)
- Marketing authorisation holder
- RATIOPHARM (ALLEMAGNE)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 16 Jul 2014
- Prescription and dispensing conditions
- Prescription only
- List II: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- Yes
BDPM identifiers
CIS
62327311CIP73696628CIP133400936966284Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALPROATE DE SODIUMcomprimé | 500 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.